Clinical Trials

RTOG 0625:
Study using Bevacizumab with Irinotecan or Bevacizumab with Temozolomide in treating Recurrent GBM

This study is being done to determine if an investigational cancer treatment for brain tumors called bevacizumab combined with either the chemotherapy agent irinotecan or the chemotherapy agent temozolomide is effective in treating glioblastoma. In addition, the side effects and safety of these treatment combinations will be determined.

For more info, contact Cindy Gu at 585-275-2525